Published in Biochemistry on February 22, 2005
Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2007) 2.06
DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol (2010) 1.89
RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochim Biophys Acta (2006) 1.35
Human subtelomeric duplicon structure and organization. Genome Biol (2007) 1.01
Immunodetection of human double homeobox 4. Hybridoma (Larchmt) (2011) 1.00
Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer. BMC Med Genomics (2009) 0.85
Multiple protein domains contribute to nuclear import and cell toxicity of DUX4, a candidate pathogenic protein for facioscapulohumeral muscular dystrophy. PLoS One (2013) 0.83
Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation. PLoS One (2016) 0.77
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A (2007) 3.32
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord (2007) 2.85
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J (2008) 2.74
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling. Hum Mol Genet (2004) 2.10
Nuclear positioning. Cell (2013) 2.01
DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol (2010) 1.89
Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest (2007) 1.87
The nuclear envelope as a signaling node in development and disease. Dev Cell (2009) 1.81
Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins. J Cell Sci (2009) 1.74
A-type lamins: guardians of the soma? Nat Cell Biol (2004) 1.68
The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure (2002) 1.64
Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet (2008) 1.64
Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement. Proc Natl Acad Sci U S A (2010) 1.61
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry (2003) 1.50
DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol (2008) 1.48
The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One (2011) 1.45
Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum Mol Genet (2006) 1.45
Human heterochromatin protein 1 isoforms HP1(Hsalpha) and HP1(Hsbeta) interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation. Mol Cell Biol (2003) 1.44
Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo. J Cell Sci (2003) 1.44
Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum Mol Genet (2007) 1.38
The nuclear envelope and human disease. Physiology (Bethesda) (2004) 1.32
Nuclear envelope proteins and neuromuscular diseases. Muscle Nerve (2003) 1.23
Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation (2010) 1.21
TAN lines: a novel nuclear envelope structure involved in nuclear positioning. Nucleus (2011) 1.20
Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med (2012) 1.19
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology (2006) 1.15
Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene. Cardiovasc Res (2011) 1.15
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins. Biochemistry (2006) 1.12
DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One (2009) 1.12
Intracellular trafficking of MAN1, an integral protein of the nuclear envelope inner membrane. J Cell Sci (2002) 1.12
Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. BMC Cell Biol (2005) 1.11
Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum Mol Genet (2006) 1.11
Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance. Dev Cell (2013) 1.07
DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med (2012) 1.06
Inner nuclear membrane proteins: impact on human disease. Chromosoma (2012) 1.05
Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet (2011) 1.04
Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin. Hum Mol Genet (2008) 1.03
The carboxyl-terminal nucleoplasmic region of MAN1 exhibits a DNA binding winged helix domain. J Biol Chem (2006) 1.03
Molecular biology and the diagnosis and treatment of liver diseases. World J Gastroenterol (1998) 1.03
LMNA cardiomyopathy: cell biology and genetics meet clinical medicine. Dis Model Mech (2011) 1.01
Portal vein thrombosis associated with Fusobacterium nucleatum septicemia in a patient with ulcerative colitis. J Clin Gastroenterol (2004) 1.01
Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. Biochim Biophys Acta (2008) 0.99
Defective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition. PLoS One (2010) 0.99
Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome. Nucleus (2011) 0.99
A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen (2006) 0.99
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med (2012) 0.99
Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene. Biochim Biophys Acta (2010) 0.98
Emerin organizes actin flow for nuclear movement and centrosome orientation in migrating fibroblasts. Mol Biol Cell (2013) 0.98
Loss of a DNA binding site within the tail of prelamin A contributes to altered heterochromatin anchorage by progerin. FEBS Lett (2010) 0.96
Emery-Dreifuss muscular dystrophy. Curr Neurol Neurosci Rep (2007) 0.95
Subcellular localization of SREBP1 depends on its interaction with the C-terminal region of wild-type and disease related A-type lamins. Exp Cell Res (2011) 0.94
Lamin A/C depletion enhances DNA damage-induced stalled replication fork arrest. Mol Cell Biol (2013) 0.94
Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology (2011) 0.94
Altered protein dynamics of disease-associated lamin A mutants. BMC Cell Biol (2004) 0.92
Primary biliary cirrhosis: report of a focus study group. Hepatology (2004) 0.92
Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology (2003) 0.92
The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy. J Biol Chem (2011) 0.91
Proteasome-mediated degradation of integral inner nuclear membrane protein emerin in fibroblasts lacking A-type lamins. Biochem Biophys Res Commun (2006) 0.91
Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development. World J Gastroenterol (2000) 0.91
Abnormal p38α mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation. Hum Mol Genet (2012) 0.90
Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins. Nucleus (2012) 0.90
Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. Am J Gastroenterol (2005) 0.90
Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation. J Biol Chem (2012) 0.89
Primary biliary cirrhosis and the nuclear pore complex. Autoimmun Rev (2012) 0.89
DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One (2013) 0.88
The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress. J Cell Mol Med (2009) 0.87
Reactivation of autophagy ameliorates LMNA cardiomyopathy. Autophagy (2012) 0.86
Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem (2013) 0.85
Gene regulation by human orthologs of Drosophila heterochromatin protein 1. Biochem Biophys Res Commun (2002) 0.85
Linker of nucleoskeleton and cytoskeleton (LINC) complex-mediated actin-dependent nuclear positioning orients centrosomes in migrating myoblasts. Nucleus (2015) 0.85
Structural analysis of the Smad2-MAN1 interaction that regulates transforming growth factor-β signaling at the inner nuclear membrane. Biochemistry (2010) 0.84
Depletion of extracellular signal-regulated kinase 1 in mice with cardiomyopathy caused by lamin A/C gene mutation partially prevents pathology before isoenzyme activation. Hum Mol Genet (2013) 0.84
Contextual automated 3D analysis of subcellular organelles adapted to high-content screening. J Biomol Screen (2010) 0.84
Perturbation of nuclear lamin A causes cell death in chondrocytes. Arthritis Rheum (2012) 0.83
Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A. Sci Signal (2013) 0.83
Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation. Skelet Muscle (2013) 0.82
Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy. J Clin Endocrinol Metab (2007) 0.81
Cardiomyocyte-specific expression of lamin a improves cardiac function in Lmna-/- mice. PLoS One (2012) 0.81
Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology (2007) 0.80
The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology (2009) 0.79
Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression. Histopathology (2011) 0.78
Hepatitis B virus reactivation after kidney transplantation and new onset lymphoma. J Clin Gastroenterol (2003) 0.78
Mitogen-activated protein kinase inhibitor regulation of heart function and fibrosis in cardiomyopathy caused by lamin A/C gene mutation. Trends Cardiovasc Med (2010) 0.78
FSHD myotubes with different phenotypes exhibit distinct proteomes. PLoS One (2012) 0.78
Cellular stress induces Bax-regulated nuclear bubble budding and rupture followed by nuclear protein release. Nucleus (2014) 0.77
New messages in the nuclear envelope. Cell Cycle (2010) 0.77
Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis. Mol Cancer (2006) 0.77
Reduction of a 4q35-encoded nuclear envelope protein in muscle differentiation. Biochem Biophys Res Commun (2009) 0.76
Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Arch (2008) 0.76
New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand. J Med Genet (2007) 0.76
Nuclear envelope regulation of signaling cascades. Adv Exp Med Biol (2014) 0.76
1H, 13C and 15N resonance assignments of the C-terminal domain of human lamin A/C. J Biomol NMR (2002) 0.76
Signaling defects and the nuclear envelope in progeria. Dev Cell (2010) 0.75
Bioartificial liver support for fulminant hepatic failure. World J Gastroenterol (1999) 0.75
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers. BMC Cancer (2014) 0.75